Error message
Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).Marksans Pharma
21 September, 2024 04:30 BSE: 524404
NSE: MARKSANSISIN: INE750C01026
Start SIP in Marksans Pharma
Start SIPMarksans Pharma Performance
Day Range
- Low 276
- High 329
52 Week Range
- Low 97
- High 329
- Open Price276
- Previous Close274
- Volume28498783
Marksans Pharma Financials
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 255 | 225 | 241 | 205 | 182 | 153 |
Operating Expenses Qtr Cr | 213 | 191 | 199 | 167 | 155 | 130 |
Operating Profit Qtr Cr | 41 | 34 | 42 | 37 | 27 | 23 |
Depreciation Qtr Cr | 7 | 7 | 8 | 8 | 5 | 4 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 1 |
Tax Qtr Cr | 10 | 5 | 9 | 13 | 10 | 5 |
Net Profit Qtr Cr | 32 | 33 | 25 | 31 | 44 | 18 |
Marksans Pharma Technicals
EMA & SMA
Current Price
₹318.35
+43.91 (16%)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹265.41
- 50 Day
- ₹233.87
- 100 Day
- ₹207.49
- 200 Day
- ₹179.91
- 20 Day
- ₹262.72
- 50 Day
- ₹225.88
- 100 Day
- ₹194.33
- 200 Day
- ₹176.02
Marksans Pharma Resistance and Support
PIVOT
₹307.72
Resistance | |
---|---|
First Resistance | 339.43 |
Second Resistance | 360.52 |
Third Resistance | 392.23 |
RSI | 74.87 |
MFI | 85.86 |
MACD Single Line | 18.56 |
MACD | 21.08 |
Support | |
---|---|
First Support | 286.63 |
Second Support | 254.92 |
Third Supoort | 233.83 |
Marksans Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 29,387,156 | 1,009,742,680 | 34.36 |
Week | 9,189,172 | 318,221,019 | 34.63 |
1 Month | 5,498,595 | 178,704,349 | 32.5 |
6 Month | 3,270,537 | 120,748,213 | 36.92 |
Marksans Pharma Result Highlights
Marksans Pharma Synopsis
NSE-Medical-Diversified
Marksans Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 853.27 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2024. Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364.Market Cap | 12,437 |
Sales | 926 |
Shares in Float | 25.38 |
No of funds | 108 |
Yield | 0.22 |
Book Value | 10.17 |
U/D Vol ratio | 2.3 |
LTDebt / Equity | |
Alpha | 0.3 |
Beta | 1.15 |
Marksans Pharma Shareholding Pattern
Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
---|---|---|---|---|
Promoters | 43.87% | 43.85% | 43.85% | 43.85% |
Mutual Funds | 2.82% | 4.23% | 3.82% | 3.15% |
Foreign Portfolio Investors | 7.71% | 4.69% | 4.67% | 4.19% |
Financial Institutions/ Banks | ||||
Individual Investors | 29.47% | 30.91% | 30.8% | 32.12% |
Others | 16.13% | 16.32% | 16.86% | 16.69% |
Marksans Pharma Management
Name | Designation |
---|---|
Mr. Mark Saldanha | Chairman & Managing Director |
Mrs. Sandra Saldanha | Whole Time Director |
Mr. Varddhman V Jain | Whole Time Director |
Dr. Sunny Sharma | Non Executive Director |
Mr. Seetharama R Buddharaju | Independent Director |
Mr. Digant Mahesh Parikh | Independent Director |
Mr. Abhinna Sundar Mohanty | Independent Director |
Mrs. Shailaja Vardhan | Independent Director |
Marksans Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Marksans Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-08-13 | Quarterly Results | |
2024-05-30 | Audited Results & Final Dividend | |
2024-02-13 | Quarterly Results | |
2023-11-09 | Quarterly Results | |
2023-08-11 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2024-09-17 | FINAL | Rs.0.60 per share(60%)Final Dividend |
2023-06-07 | FINAL | Rs.0.50 per share(50%)Final Dividend |
Marksans Pharma FAQs
What is Share Price of Marksans Pharma ?
Marksans Pharma share price is ₹318 As on 21 September, 2024 | 04:16
What is the Market Cap of Marksans Pharma ?
The Market Cap of Marksans Pharma is ₹14426.5 Cr As on 21 September, 2024 | 04:16
What is the P/E ratio of Marksans Pharma ?
The P/E ratio of Marksans Pharma is 43.2 As on 21 September, 2024 | 04:16
What is the PB ratio of Marksans Pharma ?
The PB ratio of Marksans Pharma is 6.9 As on 21 September, 2024 | 04:16